PPARG and Hepatic fibrosis: These experimental findings have recently been confirmed in vivo: HSC-specific PPARγ knockout mice are more sensitive to CCl4-induced hepatic fibrosis, and when the fibrogenic CCl4 agent is ceased, liver fibrosis in mice with specific PPARγ knockout resolves more slowly than in wild-type mice [195,198,203].